APA

Diener H. C., Dodick D. W., Aurora S. K., Turkel C. C., DeGryse R. E., Lipton R. B., Silberstein S. D. & Brin M. F. (20101116). OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. : Cephalalgia : an international journal of headache.

Chicago

Diener H C, Dodick D W, Aurora S K, Turkel C C, DeGryse R E, Lipton R B, Silberstein S D and Brin M F. 20101116. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. : Cephalalgia : an international journal of headache.

Harvard

Diener H. C., Dodick D. W., Aurora S. K., Turkel C. C., DeGryse R. E., Lipton R. B., Silberstein S. D. and Brin M. F. (20101116). OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. : Cephalalgia : an international journal of headache.

MLA

Diener H C, Dodick D W, Aurora S K, Turkel C C, DeGryse R E, Lipton R B, Silberstein S D and Brin M F. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. : Cephalalgia : an international journal of headache. 20101116.